Originally published in our sister publication, Pharmacy Practice News.
The FDA approved oliceridine (Olinvyk, Trevena), an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an IV opioid and for whom alternative treatments are inadequate.
The use of oliceridine is limited to hospitals or other controlled clinical settings, according to the FDA. It is indicated for short-term use only.
The first new chemical entity in this IV drug class in